Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit.

Potter EL, Lew TE, Sooriyakumaran M, Edwards AM, Tong E, Aung AK.

Australas J Ageing. 2019 Mar 14. doi: 10.1111/ajag.12643. [Epub ahead of print]

PMID:
30868694
2.

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.

Blombery P, Anderson MA, Gong JN, Thijssen R, Birkinshaw RW, Thompson ER, Teh CE, Nguyen T, Xu Z, Flensburg C, Lew TE, Majewski IJ, Gray DHD, Westerman DA, Tam CS, Seymour JF, Czabotar PE, Huang DCS, Roberts AW.

Cancer Discov. 2019 Mar;9(3):342-353. doi: 10.1158/2159-8290.CD-18-1119. Epub 2018 Dec 4.

PMID:
30514704
3.

A case of multi-drug resistant ESBL-producing Shigella sonnei acute acalculous cholecystitis and gastroenteritis in a returned traveller.

Williams E, Lew TE, Fuller A, Spelman DW, Jenney AW.

J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay029.

PMID:
30169854
4.

Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.

Anderson MA, Tam C, Lew TE, Juneja S, Juneja M, Westerman D, Wall M, Lade S, Gorelik A, Huang DCS, Seymour JF, Roberts AW.

Blood. 2017 Jun 22;129(25):3362-3370. doi: 10.1182/blood-2017-01-763003. Epub 2017 May 4.

5.

Early serum creatinine accurately predicts acute kidney injury post cardiac surgery.

Grynberg K, Polkinghorne KR, Ford S, Stenning F, Lew TE, Barrett JA, Summers SA.

BMC Nephrol. 2017 Mar 16;18(1):93. doi: 10.1186/s12882-017-0504-y.

6.

Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.

Chan KL, Lokan J, Tam CS, Lew TE, Prince HM.

Leuk Lymphoma. 2017 Jan;58(1):207-210. Epub 2016 Jun 21. No abstract available.

PMID:
27326828
7.

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.

Lew TE, Cheah CY, Carney DA, Prince HM, Wolf M, Bazargan A, Januszewicz EH, Filshie R, Westerman D, Seymour JF, Tam CS.

Leuk Lymphoma. 2016 May;57(5):1044-53. doi: 10.3109/10428194.2015.1096353. Epub 2015 Nov 20.

PMID:
26464106
8.

Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.

Cheah CY, Lew TE, Seymour JF, Burbury K.

Acta Haematol. 2013;130(4):254-9. doi: 10.1159/000351048. Epub 2013 Jul 11.

9.

All is not lost--the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.

Cheah CY, Lew TE, Lee R, Tam CS, Seymour JF, Carney DA.

Eur J Haematol. 2013 Aug;91(2):189-90. doi: 10.1111/ejh.12138. Epub 2013 Jun 28. No abstract available.

PMID:
23668259
10.

Fenthion poisoning of wading birds.

Zinkl JG, Jessup DA, Bischoff AI, Lew TE, Wheeldon EB.

J Wildl Dis. 1981 Jan;17(1):117-9. No abstract available.

PMID:
7253093

Supplemental Content

Support Center